The top ten risks and opportunities for 2021
It’s not being called the “year from hell” for nothing. The pandemic, the kind of “grey swan” event that is predicted but never pinpointed in time, finally came calling in 2020, aggravated by deepening political division and tribalism. International institutions continued to fragment, with the United States withdrawing from the World Health Organization right in the middle of the plague and engaging in obstructionist behavior in other multilateral organizations.
Yet there were rays of light even in the abyss. Democracy prevailed in the US presidential election, even as the US political system remains polarized and dysfunctional. In a surge of spectacular innovation, aided by artificial intelligence and big data, scientists created COVID-19 vaccines with stunning alacrity.
Share
The U.S. FDA announced today an Emergency Use Authorization for the first over-the-counter COVID-19 diagnostic test for home use.
Developed by Australian digital diagnostics company Ellume Health, the single-use kit is accompanied by a Bluetooth-connected app that guides users through the testing process and automatically reports its results for disease monitoring.
The test returns its results in 15 to 20 minutes. It s intended for use with self-collected nasal swab samples from individuals aged 16 years or older, or adult-collected samples from children aged two years or older.
The Ellume COVID-19 Home Test kit comes with a sterile nasal swab with a child adapter, processing fluid, a dropper and a Bluetooth-connected sample analyzer. Users are instructed to download the accompanying Ellume COVID-19 Home Test App for iOS or Android, which includes a quick start guide on how to connect the app to the analyzer as well as an instructional video on how to collect a sample a
COVID-19 in Wisconsin: 74 new deaths, 2,402 new cases Photo: NIAID-RML via AP. FILE - This undated electron microscope image made available by the U.S. National Institutes of Health in February 2020 shows the Novel Coronavirus SARS-CoV-2. Also known as 2019-nCoV, the virus causes COVID-19. The sample was isolated from a patient in the U.S. On Tuesday, April 21, 2020, U.S. health regulators OK d the first coronavirus test that allows people to collect their own sample at home, a new approach that could help expand testing options in most states. The sample will still have to be shipped for processing back to LabCorp, which operates diagnostic labs throughout the U.S.
Sickle Cell Puts Black Patients at Higher Risk for Severe COVID-19 1490wosh.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 1490wosh.com Daily Mail and Mail on Sunday newspapers.
US approval of Brisbane company s COVID test kit very pleasing
We’re sorry, this service is currently unavailable. Please try again later.
Dismiss
US approval of Brisbane company s COVID test kit very pleasing
Normal text size
Advertisement
Brisbane-based biotech company Ellume has been awarded FDA approval in the United States for its home COVID-19 test to be rolled out.
The kits will not require a prescription and will be able to be bought over the counter at pharmacies, a move that will expand, it is hoped, testing options for people as coronavirus continues to run rampant through the country.
Dr Sean Parsons, founder of Brisbane biotech company Ellume, which has been given US FDA approval for its rapid COVID-19 home test kits.